cRGD-modified nanoparticles of multi-bioactive agent conjugate with pH-sensitive linkers and PD-L1 antagonist for integrative collaborative treatment of breast cancer

Nanoscale Horiz., 2023, 8,870-886
DOI: 10.1039/D2NH00590E, Communication

Chenming Zou, Yuepeng Tang, Ping Zeng, Derong Cui, Majdi Al Amili, Ya Chang, Zhu Jin, Yuanyuan Shen, Songwei Tan, Shengrong Guo
cRGD-modified nanoparticles (cRGD-TDA NPs) of a multi-bioactive agent conjugate for powerfully eliciting an immunogenic cell death (ICD) effect and enhancing cancer chemoimmunotherapy combined with PD-L1 antagonists.
The content of this RSS Feed (c) The Royal Society of Chemistry